Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Andries

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 19, 2020
DAPT Duration: When Less Is MoreMarc Cohen, Gabriela Andries
Expert Opinion on Drug Safety|August 18, 2018
Benefit-risk review of different drug classes used in chronic heart failureGabriela Andries, Srikanth Yandrapalli, Wilbert S Aronow
Vascular Health and Risk Management|October 19, 2017
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectivesSrikanth Yandrapalli, Gabriela Andries, Medha Biswas, et al.
Journal of Thoracic Disease|August 26, 2017
Complete versus culprit only revascularization in ST-elevation myocardial infarction-a perspective on recent trials and recommendationsGabriela Andries, Sahil Khera, Robert J Timmermans, et al.
Cardiology in Review|May 11, 2018
Novel Pharmacotherapy in Hypertrophic CardiomyopathyGabriela Andries, Srikanth Yandrapalli, Srihari S Naidu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2023
Long term follow-up of the tacrolimus in combination, tacrolimus alone compared (TICTAC) trialDavid A Baran, Saurabh Kapoor, Jagpreet Grewal, et al.
Expert Opinion on Investigational Drugs|December 25, 2018
Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agentsSrikanth Yandrapalli, Gabriela Andries, Shashvat Gupta, et al.
Drugs & Aging|January 8, 2019
Drug Therapy of Dyslipidemia in the ElderlySrikanth Yandrapalli, Shashvat Gupta, Gabriela Andries, et al.
Respiratory Medicine Case Reports|February 3, 2022
Recurrent Silicone Embolism Syndrome requiring VA ECMONikhil Madan, Umair Khan, Anthony Martins, et al.
The Journal of Invasive Cardiology|December 17, 2021
Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive CardiomyopathySrikanth Yandrapalli, Prakash Harikrishnan, Gabriela Andries, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 19, 2020
DAPT Duration: When Less Is MoreMarc Cohen, Gabriela Andries
Expert Opinion on Drug Safety|August 18, 2018
Benefit-risk review of different drug classes used in chronic heart failureGabriela Andries, Srikanth Yandrapalli, Wilbert S Aronow
Vascular Health and Risk Management|October 19, 2017
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectivesSrikanth Yandrapalli, Gabriela Andries, Medha Biswas, et al.
Journal of Thoracic Disease|August 26, 2017
Complete versus culprit only revascularization in ST-elevation myocardial infarction-a perspective on recent trials and recommendationsGabriela Andries, Sahil Khera, Robert J Timmermans, et al.
Cardiology in Review|May 11, 2018
Novel Pharmacotherapy in Hypertrophic CardiomyopathyGabriela Andries, Srikanth Yandrapalli, Srihari S Naidu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2023
Long term follow-up of the tacrolimus in combination, tacrolimus alone compared (TICTAC) trialDavid A Baran, Saurabh Kapoor, Jagpreet Grewal, et al.
Expert Opinion on Investigational Drugs|December 25, 2018
Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agentsSrikanth Yandrapalli, Gabriela Andries, Shashvat Gupta, et al.
Drugs & Aging|January 8, 2019
Drug Therapy of Dyslipidemia in the ElderlySrikanth Yandrapalli, Shashvat Gupta, Gabriela Andries, et al.
Respiratory Medicine Case Reports|February 3, 2022
Recurrent Silicone Embolism Syndrome requiring VA ECMONikhil Madan, Umair Khan, Anthony Martins, et al.
The Journal of Invasive Cardiology|December 17, 2021
Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive CardiomyopathySrikanth Yandrapalli, Prakash Harikrishnan, Gabriela Andries, et al.
Pageof 2